Postbiotics vs. Fish Oil for Dog Inflammation: Which Actually Helps More?

By Koranda Walsh, VMD, DACVIM (SAIM), DACVP (CP)

✓ Medically reviewed by Koranda Walsh, VMD, DACVIM (SAIM), DACVP (CP) — August 6, 2026 For general education — not a substitute for veterinary care.

Value · August 10, 2026 · 6 min read

The bloodwork and the trial data point the same direction — fish oil has the deeper evidence trail for inflammation, postbiotics are still catching up.

I get asked this in exam room consults more than almost any other supplement question: postbiotics or fish oil, which one actually calms inflammation? Owners have usually already read a chewy postbiotic label promising “gut-immune balance” right next to a fish oil bottle promising “supports healthy joints,” and they want to know which claim is real. My answer, every time, is the same signature move I use on every supplement question: read the label and the bloodwork before the claim. One of these categories has a stack of randomized, placebo-controlled dog trials behind it. The other has real mechanistic promise and thin, inconsistent dog-specific data. Those are not the same thing, even though they get marketed the same way.

The limitation nobody puts on either label

Start with what the newest postbiotic evidence actually says, because it is more sobering than the marketing copy suggests. A 2025 systematic review and meta-analysis in Microorganisms pooled 69 studies that met inclusion criteria, with only 13 being in vivo trials in actual dogs. When the authors ran the meta-analysis on the outcomes that mattered — inflammatory and immune markers among them — they found no statistically significant differences between postbiotic and control groups. That is not a rejection of postbiotics as a concept; the mechanism is plausible and the review notes real anti-inflammatory signal in other species. But if a label tells you a postbiotic will calm your dog’s inflammation, the review the label is built on doesn’t yet support that as a settled finding in dogs specifically. Sample sizes are small, strains vary study to study, and doses are rarely standardized enough to compare head-to-head.

Fish oil’s limitation is different, and less about whether it works — the randomized trial data on fish oil and canine osteoarthritis is genuinely strong. The limitation is dosing and sourcing. A multicenter, randomized, double-blinded trial covered in Journal of the American Veterinary Medical Association: JAVMA followed 127 client-owned dogs with osteoarthritis across 18 private clinics and found that by day 42, crepitus, pain, and joint effusion had improved by roughly 50% in the fish-oil group while remaining essentially unchanged on placebo. That is a real, replicated effect. But “fish oil” on a label can mean almost any EPA/DHA concentration, and most bottles don’t tell you the actual milligram dose per pound of dog — which is the number that determines whether you’re feeding a therapeutic dose or a rounding error.

What each one is actually doing inside the dog

Fish oil’s anti-inflammatory mechanism is well characterized. EPA and DHA — the two long-chain omega-3s in fish oil — partially displace arachidonic acid from cell membranes, which shifts the eicosanoid pathway toward less inflammatory signaling molecules. In animal studies this measurably reduces inflammatory marker expression, cartilage degradation, and oxidative stress in chondrocytes, the cartilage cells most affected in osteoarthritis. A related trial, also multicenter and randomized, found that dogs on osteoarthritis-appropriate carprofen doses could often have their carprofen dosage reduced when fish oil was added to the diet — a clinically meaningful finding because it means fewer owners are choosing between joint pain control and NSAID side effects.

Postbiotics work through a different door entirely: gut microbiota modulation, short-chain fatty acid production, mucosal immune signaling, and tight-junction protein upregulation in the gut lining. That is a real and interesting pathway, and it’s the reason postbiotics get paired with atopic dermatitis and gut-inflammation claims rather than joint claims. A study in Pets looking at a probiotic-prebiotic-yeast extract supplement in healthy dogs did find reduced gut inflammation markers and improved gut bacterial populations — but that is a gut-localized effect in healthy dogs, not evidence that postbiotics reduce systemic or joint inflammation the way fish oil has been shown to in arthritic dogs. If your dog’s inflammation is joint-based, a postbiotic is answering a different question than the one you’re asking.

In my practice, I’ve watched this distinction get missed constantly. A twelve-year-old, 58-pound mixed-breed named Otis came in because his owner had noticed him hesitating at the bottom of the porch steps every morning for about three weeks — not refusing them, just pausing, weight-shifting, before committing. She’d already started him on a postbiotic gut chew a friend recommended, reasoning that “inflammation is inflammation.” Bloodwork and orthopedic exam pointed to early bilateral hip changes, not a gut issue. We didn’t abandon the postbiotic — there was no harm in it — but we added a dosed fish oil at a therapeutic EPA/DHA level and reassessed at six weeks. That single case isn’t proof of anything on its own, and I don’t treat it as data. It’s the pattern that made me start asking every owner what, specifically, they observed and where, before recommending either category.

Reading the label and the bloodwork before you commit

A practical sequence, in the order I actually walk owners through it:

First, localize the problem. Gut symptoms — soft stool, gas, food sensitivity flares, skin flares tied to diet — point toward the postbiotic/probiotic category. Joint stiffness, reduced activity tolerance, reluctance on stairs, or a vet-confirmed osteoarthritis diagnosis point toward fish oil, where the trial evidence is strongest.

Second, check the dose, not the ingredient list. For fish oil, that means EPA+DHA milligrams per pound of body weight on the label — not total fish oil milligrams, which pads the number with less-active fatty acids. For postbiotics, check whether the strain and concentration are disclosed at all; many labels list only “postbiotic blend” with no strain ID, which makes the product impossible to compare against any published study.

Third, verify third-party testing. Products carrying the PetMD: National Animal Supplement Council seal have undergone independent quality-control audits and random product testing, which at minimum tells you the bottle contains what the label claims — a baseline that a surprising number of supplements fail.

Fourth, give it a real trial window and reassess with your vet, using an observable marker — stairs, willingness to jump onto furniture, gait after rest — rather than a vague “seems better.”

If your dog is also taking a human probiotic capsule at home for any reason, it’s worth checking whether that product carries any hidden risk; our guide on whether a human probiotic capsule contains xylitol unsafe for dogs walks through exactly what to check on that label. And if you’re still deciding whether your dog needs a probiotic or postbiotic at all before adding fish oil to the mix, our whole-patient guide to the signs your dog needs a probiotic is the better starting point than guessing from marketing copy.

Where I land, and the honest counterargument

The evidence-bounded recommendation: for inflammation with a joint or mobility component, fish oil dosed at a real therapeutic EPA/DHA level has the deepest and most replicated trial support in dogs, backed by multiple randomized, multicenter studies. Postbiotics are a legitimate, mechanistically sound category for gut-localized inflammation, but the current dog-specific meta-analytic evidence doesn’t yet support them as an inflammation solution outside the gut.

The strongest counterargument, and it’s a fair one: inflammation isn’t always neatly siloed to one organ system, and a dog with chronic low-grade gut dysbiosis can plausibly run a higher systemic inflammatory baseline that affects joints indirectly. Some of the postbiotic research on atopic dermatitis supports at least a systemic immune-modulating role. I don’t dismiss that. But “plausible systemic effect” and “proven anti-inflammatory effect at a specific joint” are different tiers of evidence, and a label that blurs them is asking you to trust the marketing over the bloodwork.

In my practice, the owners who get the best results aren’t the ones who pick a side and stay there — they’re the ones like Otis’s owner, once we recalibrated: she kept the gut-support product because he tolerated it well and it wasn’t doing harm, added a properly dosed fish oil for the joint component we’d actually diagnosed, and came back at six weeks with a phone video of him taking the porch steps without the pause. I want to be careful here — that’s one dog, one owner’s observation, not a trial outcome, and I’d never present it as more than that. What it illustrates is the process, not the proof: separate what you’re treating from what you’re hoping, dose to the number on a real study, and verify the bottle actually contains what it claims before you decide either ingredient “worked” or “didn’t.”